Genesis Therapeutics
Matteus Pan is a product professional who started their career in technology at The Boston Consulting Group before transitioning to product management roles at various tech companies such as Dropbox, Bina Technologies, Roche, and Genentech. Currently, Pan is diligently working on digital therapeutics in autism/neuroscience at Genentech and has a background in computer science and economics from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Genesis Therapeutics
3 followers
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies.